Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Don Trump Jr. Applauds Cuban Protesters, Denounces Communism

Don Trump Jr. weighed in on the Democrats’ failure to denounce…
Read more

Biden Looks to Set up ‘Red Phone’ to China

The Biden administration is looking to set up communications…
Read more

Critics Slam The White House After Psaki Reveals It’s Consulting with Facebook to ‘Flag Misinformation’

Critics roundly condemned the White House after press secretary…
Read more